Literature DB >> 10223949

N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity.

H Wakabayashi1, H Matsumoto, K Hashimoto, S Teraguchi, M Takase, H Hayasawa.   

Abstract

N-acylated or D enantiomer peptide derivatives based on the sequence RRWQWRMKK in lactoferricin B demonstrated antimicrobial activities greater than those of lactoferricin B against bacteria and fungi. The most potent peptide, conjugated with an 11-carbon-chain acyl group, showed two to eight times lower MIC than lactoferricin B.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10223949      PMCID： PMC89256     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.

Authors:  D S Chapple; D J Mason; C L Joannou; E W Odell; V Gant; R W Evans
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Synthetic magainin analogues with improved antimicrobial activity.

Authors:  H C Chen; J H Brown; J L Morell; C M Huang
Journal:  FEBS Lett       Date:  1988-08-29       Impact factor: 4.124

3.  Antibacterial activity in bovine lactoferrin-derived peptides.

Authors:  K S Hoek; J M Milne; P A Grieve; D A Dionysius; R Smith
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

4.  Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents.

Authors:  H Wakabayashi; S Abe; T Okutomi; S Tansho; K Kawase; H Yamaguchi
Journal:  Microbiol Immunol       Date:  1996       Impact factor: 1.955

5.  Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin.

Authors:  J H Kang; M K Lee; K L Kim; K S Hahm
Journal:  Int J Pept Protein Res       Date:  1996-10

6.  Role of cell-binding in the antibacterial mechanism of lactoferricin B.

Authors:  W R Bellamy; H Wakabayashi; M Takase; K Kawase; S Shimamura; M Tomita
Journal:  J Appl Bacteriol       Date:  1993-11

7.  Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus.

Authors:  J Alvarez-Bravo; S Kurata; S Natori
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

8.  Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin.

Authors:  W Bellamy; M Takase; H Wakabayashi; K Kawase; M Tomita
Journal:  J Appl Bacteriol       Date:  1992-12

9.  Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds.

Authors:  H Wakabayashi; S Abe; S Teraguchi; H Hayasawa; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

10.  Antibacterial activity of peptides homologous to a loop region in human lactoferrin.

Authors:  E W Odell; R Sarra; M Foxworthy; D S Chapple; R W Evans
Journal:  FEBS Lett       Date:  1996-03-11       Impact factor: 4.124
View more
  35 in total

1.  N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide.

Authors:  C Chicharro; C Granata; R Lozano; D Andreu; L Rivas
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

2.  Studies on lactoferricin-derived Escherichia coli membrane-active peptides reveal differences in the mechanism of N-acylated versus nonacylated peptides.

Authors:  Dagmar Zweytick; Günter Deutsch; Jörg Andrä; Sylvie E Blondelle; Ekkehard Vollmer; Roman Jerala; Karl Lohner
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

3.  Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions.

Authors:  Tali Rydlo; Shahar Rotem; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance.

Authors:  Brian C Monk; Kyoko Niimi; Susan Lin; Allison Knight; Thomas B Kardos; Richard D Cannon; Rekha Parshot; Amanda King; David Lun; David R K Harding
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 5.  Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action.

Authors:  Maria Luisa Mangoni; Yechiel Shai
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

6.  Membrane potential is vital for rapid permeabilization of plasma membranes and lipid bilayers by the antimicrobial peptide lactoferricin B.

Authors:  Farzana Hossain; Md Mizanur Rahman Moghal; Md Zahidul Islam; Md Moniruzzaman; Masahito Yamazaki
Journal:  J Biol Chem       Date:  2019-05-22       Impact factor: 5.157

Review 7.  Alpha-helical cationic antimicrobial peptides: relationships of structure and function.

Authors:  Yibing Huang; Jinfeng Huang; Yuxin Chen
Journal:  Protein Cell       Date:  2010-02-06       Impact factor: 14.870

8.  De Novo Designed Amphipathic α-Helical Antimicrobial Peptides Incorporating Dab and Dap Residues on the Polar Face To Treat the Gram-Negative Pathogen, Acinetobacter baumannii.

Authors:  Colin T Mant; Ziqing Jiang; Lajos Gera; Tim Davis; Kirsten L Nelson; Shaun Bevers; Robert S Hodges
Journal:  J Med Chem       Date:  2019-03-21       Impact factor: 7.446

9.  Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.

Authors:  José María Saugar; María Jesús Rodríguez-Hernández; Beatriz G de la Torre; María Eugenia Pachón-Ibañez; María Fernández-Reyes; David Andreu; Jerónimo Pachón; Luis Rivas
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

10.  Lipophilic lysine-spermine conjugates are potent polyamine transport inhibitors for use in combination with a polyamine biosynthesis inhibitor.

Authors:  Mark R Burns; Gerard F Graminski; Reitha S Weeks; Yan Chen; Thomas G O'Brien
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.